Growth charts for individuals with Smith-Lemli-Opitz syndrome

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 11, 2012, Pages 2707-2713

  Lee, Ryan W Y ^a,b,c   Mcgready, John ^d   Conley, Sandra K ^a   Yanjanin, Nicole M ^a   Nowaczyk, Małgorzata J M ^e   Porter, Forbes D ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Anthropometry; Growth; Head circumference; Height; SLOS; Smith Lemli Opitz Syndrome; Weight

Indexed keywords

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; GROWTH CURVE; GROWTH RETARDATION; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFERENCE VALUE; SMITH LEMLI OPITZ SYNDROME; STATISTICAL ANALYSIS;

ADOLESCENT; BODY WEIGHTS AND MEASURES; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH CHARTS; HUMANS; INFANT; MALE; MARYLAND; SMITH-LEMLI-OPITZ SYNDROME;

EID: 84867883293     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35376     Document Type: Article

References (27)

1. Battaile KP, Battaile BC, Merkens LS, Maslen CL, Steiner RD. 2001. Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome. Mol Genet Metab 72: 67-71.
2. Elias ER, Irons MB, Hurley AD, Tint GS, Salen G. 1997. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet 68: 305-310.
3. Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, Utermann G, Moebius FF. 1998. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA 95: 8181-8186.
4. Haas D, Garbade SF, Vohwinkel C, Muschol N, Trefz FK, Penzien JM, Zschocke J, Hoffmann GF, Burgard P. 2007. Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS). J Inherit Metab Dis 30: 375-387.
5. Hoover-Fong JE, McGready J, Schulze KJ, Barnes H, Scott CI. 2007. Weight for age charts for children with achondroplasia. Am J Med Genet Part A 143A: 2227-2235.
6. Irons M, Elias ER, Salen G, Tint GS, Batta AK. 1993. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341(8857): 1414.
7. Irons M, Elias ER, Abuelo D, Bull MJ, Greene CL, Johnson VP, Keppen L, Schanen C, Tint GS, Salen G. 1997. Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. Am J Med Genet 68: 311-3314.
8. Jira PE, Wevers RA, de Jong J, Rubio-Gozalbo E, Janssen-Zijlstra FS, van Heyst AF, Sengers RC, Smeitink JA. 2000. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. J Lipid Res 41: 1339-1346.
9. Kelley RI, Hennekam RC. 2000. The Smith-Lemli-Opitz syndrome. J Med Genet 37: 321-335.
10. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegel KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. 2000. CDC growth charts: United States. Adv Data 314: 1-27.
11. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegel KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2002. 2000 CDC Growth Charts for the United States: Methods and development. Vital Health Stat 11(246): 1-190.
12. Nowaczyk MJ, Nakamura LM, Eng B, Porter FD, Waye JS. 2001. Frequency and ethnic distribution of the common DHCR7 mutation in Smith-Lemli-Opitz syndrome. Am J Med Genet 102: 383-386.
13. Nwokoro NA, Mulvihill JJ. 1997. Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome. Am J Med Genet 68: 315-321.
14. Porter FD. 2000. RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab 71: 163-174.
15. Porter FD. 2003. Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr 15: 607-613.
16. R Development Core Team. 2010. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria: ISBN 3-900051-07-0, URL http://www.R-project.org/.
17. Ryan AK, Bartlett K, Clayton P, Eaton S, Mills L, Donnai D, Winter RM, Burn J. 1998. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 35: 558-565.
18. Sikora DM, Ruggiero M, Petit-Kekel K, Merkens LS, Connor WE, Steiner RD. 2004. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome. J Pediatr 144: 783-791.
19. Starck L, Lövgren-Sandblom A, Björkhem I. 2002. Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome. J Intern Med 252: 314-321.
20. Stasinopoulos DM. 2005. Generalized additive models for location, scale and shape, (with discussion), Appl Statist 54(3): 507-554.
21. Stasinopoulos DM, Rigby B, Akantziliotou C. 2008. Instructions on how to use the gamlss package in R, Second Edition. ( http://gamlss.org/images/stories/papers/gamlss-manual.pdf, last accessed 11/29/201).
22. StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX. StataCorp LP.
23. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330: 107-113.
24. Tsukahara M, Fujisawa K, Yamamoto K, Hasui M, Saito C, Yamamaka T, Honda A, Honda M, Tint GS, Salen G. 1998. Smith-Lemli-Opitz syndrome in Japan. Am J Med Genet 75: 118-119.
25. Wassif CA, Maslen C, Kachilele-Linjewile S, Lin D, Linck LM, Connor WE, Steiner RD, Porter FD. 1998. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 63: 55-62.
26. Waterham HR, Wijburg FA, Hennekam RC, Vreken P, Poll-The BT, Dorland L, Duran M, Jira PE, Smeitink JA, Wevers RA, Wanders RJ. 1998. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet 63: 329-338.
27. Wright BS, Nwokoro NA, Wassif CA, Porter FD, Waye JS, Eng B, Nowaczyk MJ. 2003. Carrier frequency of the RSH/Smith-Lemli-Opitz IVS8-1G>C mutation in African Americans. Am J Med Genet Part A 120A: 139-141.